Updated:
B-FLEXION
Northill was founded in 2010 by Jon Little with backing from the Bertarelli Family and assistance from Jeremy Bassil and Rick Potter. The firm provides equity...
B-FLEXION
Northill was founded in 2010 by Jon Little with backing from the Bertarelli Family and assistance from Jeremy Bassil and Rick Potter. The firm provides equity and seed capital to select start-ups and early-stage managers. It also offers equity capital to replace existing shareholders in larger asset managers.
General information
Firm type
Single Family Office
Year founded
2010
AUM
Undisclosed
Location
Region
Europe
Country
United Kingdom
City
London
Corporate office
London, United Kingdom
Sector focus
Frequently asked questions
How is B-FLEXION structured compared to a traditional family office?
B-FLEXION combines direct ownership of operating businesses — primarily in life sciences — with a portfolio of asset managers it seeds, acquires, or partners with. Unlike a single-family office that primarily allocates to third-party funds, B-FLEXION takes an ‘active owner’ role in the managers themselves, institutionalizing family capital alongside outside investors across multiple strategies (per the firm, 2024).
What does B-FLEXION invest in directly?
The group reports direct holdings in operating companies focused on life sciences, healthcare services, and digital health, continuing a heritage rooted in biopharmaceuticals. No individual direct-company names are publicly disclosed.
Who makes investment decisions at B-FLEXION?
B-FLEXION has not publicly named key principals or an investment committee. The firm emphasizes talent development and institutional private-equity disciplines but does not disclose individual decision-makers.
Does B-FLEXION manage third-party capital?
Yes. B-FLEXION partners with ‘sophisticated capital’ and operates asset managers that are separate legal entities (per the firm, 2024). This implies the group both manages family capital and attracts external institutional investors across its seeded and acquired firms.
Where does B-FLEXION's underlying wealth come from?
The wealth originated from a multi-generational, family-owned biopharmaceutical company. The firm publicly acknowledges building on that heritage but does not name the company or the founding family.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: